HOFT:NASDAQHooker Furnishings Corporation Analysis
Data as of 2026-06-21 - not real-time
$15.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Hooker Furnishings is trading at $15.80, comfortably above its 20‑day SMA ($13.51) and 50‑day SMA ($13.20), while the 200‑day SMA ($11.93) remains well below current levels, underscoring a sustained bullish bias. The RSI sits at 66.5, indicating momentum but still below overbought territory, and the MACD histogram is positive (0.34) with a bullish signal line crossover, reinforcing the upward trend. Volume is on an increasing trajectory, and price action respects a clear support zone near $11.84, with resistance around $16.41, suggesting limited downside risk in the near term. However, the 30‑day volatility is exceptionally high at 84%, and the computed beta of 0.65 points to moderate market sensitivity despite the sector’s cyclical nature.
Fundamentally, the company just reported a return to profitability in Q1 FY27, posting a modest net income of $1.1 million and raising its quarterly dividend to $0.115 per share, which aligns with a generous 3.62% yield and a very low payout ratio of 6.5%. The DCF fair value of $40.26 implies a potential upside of roughly 7.6% over the current price, while the forward P/E of 11.8 and a price‑to‑book near parity suggest the stock is fairly priced on a value basis. Nonetheless, revenue contraction (‑2.4%), negative profit margin, and a high debt‑to‑equity ratio (≈13.9) introduce earnings volatility, and a shareholder investigation adds a layer of governance risk.
Fundamentally, the company just reported a return to profitability in Q1 FY27, posting a modest net income of $1.1 million and raising its quarterly dividend to $0.115 per share, which aligns with a generous 3.62% yield and a very low payout ratio of 6.5%. The DCF fair value of $40.26 implies a potential upside of roughly 7.6% over the current price, while the forward P/E of 11.8 and a price‑to‑book near parity suggest the stock is fairly priced on a value basis. Nonetheless, revenue contraction (‑2.4%), negative profit margin, and a high debt‑to‑equity ratio (≈13.9) introduce earnings volatility, and a shareholder investigation adds a layer of governance risk.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMAs, bullish MACD)
- Increasing volume and strong dividend yield
- Recent return to profitability
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF‑derived upside and forward P/E indicating value appeal
- Sustained dividend payments with low payout ratio
- Technical momentum likely to carry price toward resistance
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High volatility and cyclical sector exposure
- Elevated debt‑to‑equity and ongoing revenue decline
- Shareholder investigation creating governance uncertainty
Key Metrics & Analysis
Financial Health
Revenue Growth-2.40%
Profit Margin-8.27%
P/E Ratio11.8
ROE-6.03%
ROA0.24%
Debt/Equity13.94
P/B Ratio1.0
Op. Cash Flow$20.1M
Free Cash Flow$33.8M
Technical Analysis
TrendBullish
RSI66.5
Support$11.84
Resistance$16.41
MA 20$13.51
MA 50$13.20
MA 200$11.93
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair Value$40.26
Target Price$17.00
Upside/Downside7.59%
GradeUndervalued
TypeValue
Dividend Yield3.62%
Risk Assessment
Beta0.65
Volatility84.15%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.